home

Current Vaccines in Development

University labs, Military labs, new Labs Developing Vaccines

A number of universities around the country are working on bioterrorism vaccine development, and/or the creation of bioterrorism labs. This section contains news from university labs, military labs, and new bioterrorism labs now being built.

Recent Articles:
Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains
Of special notes in this article:
U.S. Army researchers will also report success in mouse experiments with a four-in-one vaccine...


Unused anthrax shots cost millions
Note: Originally posted Oct. 23, 2007:
WASHINGTON (AP) -- The government stands to waste $100 million a year if two agencies cannot agree ...


Facility Seeks New Anthrax Vaccine
If a large-scale anthrax attack strikes a big U.S. city a decade from now, citizens could be protected because of the work of a local nonprofit to dev...

more...

Tularemia

Tularemia, a bacterial disease, is also known as rabbit fever; symptoms include high fever, chills, aches and swollen lymph glands. Tularemia usually ...more

Recent Articles:
Tularemia-specific antibodies protect mice from developing respiratory tularemia
The respiratory form of tularemia, a potentially serious bacterial disease, is a significant public health concern because it is highly infectious, it...


The University of New Mexico and Cerus Receive $23 Million to Develop Tularemia Vaccine
Cerus Corporation (Nasdaq:CERS) and the University of New Mexico (UNM) today announced the funding of a consortium designed to develop a prophylactic ...


Large tularemia vaccine contracts among new NIAID biodefense awards
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced that it has recently mad...



Smallpox vaccine

Smallpox is a serious, contagious, and sometimes fatal infectious disease. There is no specific treatment for smallpox disease, and the only preventio...more

Recent Articles:
Smallpox, HIV: Oil-based Nasal Vaccine Technique Produces Immunity
ScienceDaily (Feb. 28, 2008)  A novel technique for vaccinating against a variety of infectious diseases -- using an oil-based emulsion placed in th...


Replacement for smallpox vaccine found
Washington, Jan 10: Researchers have found a potential alternative to the existing smallpox vaccine, which causes serious complications in some people...


Bavarian Nordic gets $25m milestone payment from US govt
Bavarian Nordic said it received a US $25 million milestone payment from the US authorities under its contract to manufacture and deliver 20 million d...

more...

Ricin Vaccine

Ricin is a poison that can be made from the waste left over from processing castor beans. It can be in the form of a powder, a mist, or a pellet, or...more

Recent Articles:
Understanding Ricin
[&] The Las Vegas incident is the latest in a line of ricin-related episodes stretching back decades. The toxin first made news in 1978, when Bulgari...


Ricin vaccine money could be better spent elsewhere, experts say
*Money needed to develop a ricin vaccine could be better spent, security experts say The deadliest attack by international terrorists in U.S. history...


DOR BioPharma Reports Successful Completion of 1 Year Interim Analysis of RiVax(TM) Stability
MIAMI, FL--(MARKET WIRE)--Mar 13, 2007 -- DOR BioPharma, Inc. (OTC BB:DORB.OB - News) ("DOR," or "The Company") announced today that it has successful...

more...

Remediation Technology

This section is for those new and evolving technologies that are meant to clean up after bioterrorism substances and other harsh substances.

Recent Articles:
Shine Holdings Announces Patent Filing for Bioremediation Process
Shine Holdings, Inc. (OTC: SHDG) has announced today the filing of a provisional patent for a remediation process against possible bioterror agents su...



Radiation/Nuclear War

We're not kidding. A possible vaccine is being developed to reduce the fatalities in event of nuclear war. Human volunteers will be needed. Guess who would be the most likely people asked or ordered to volunteer?

Recent Articles:
Hollis-Eden: BioDefense Drug Neumune's Failure Sickens Shareholders
Drug developer Hollis-Eden Pharmaceuticals Inc. (NasdaqGM: HEPH) said last week that the Department of Health and Human Services rejected the company'...


New Nuclear Radiation Treatment
. . .A California pharmaceutical firm, Hollis-Eden, is working with the Armed Forces Radiobiology Research Institute to develop a steroid hormone that...



Plague Vaccine

Plague vaccine is an active immunizing agent used to prevent infection by plague bacteria. It works by causing your body to produce its own protection...more

Recent Articles:
How plague-causing bacteria disarm host defense
Effector proteins are the bad guys that help bacterial pathogens do their job of infecting the host by crippling the body's immune system. In essence...


Wake Forest Researchers Find Vaccine Effective Against Plague
A feared potential weapon of terrorists might have been stopped in its tracks.

Researchers at Wake Forest University School of Medici...


New Combination Vaccine Effective Against Plague
Plague, a bacterium that ravaged Europe in the Middle Ages and is today one of the most feared potential agents of bio-terrorism, may have met its mat...

more...

Military Vaccines

The article attached to this is a table listing required military vaccines.

Recent Articles:
Medical Researcher to Develop Oral Vaccine
A Texas A&M University health sciences researcher has received a $2.6 million U.S. Army grant to create a new method of vaccine delivery for military ...


Extension, expiration, destruction of lots of anthrax, smallpox vaccines
Scroll down to bottom of this linked page for this clickable information:
MMQC-05-1155 22 Jun 05 SMALLPOX VACCINE DATE EXTENSION NOTIFICATIO...


Further list of military vaccines
When you click on this link, note menu at left.

more...

Malaria vaccine

Malaria continues to claim an estimated 2 to 3 million lives annually and to account for untold morbidity in the approximately 300 to 500 million peop...more

Recent Articles:
GenVec, US Military pact for pre-clinical testing of malaria vaccine
GenVec, Inc. has entered into a collaborative research and development agreement (CRADA) with the US Military Malaria Vaccine Program at the Walter Re...


Sanaria gets $4M in gov't funds for malaria vaccine
Sanaria has snagged a research grant worth more than $4 million from the Army to work on a malaria vaccine, which the biotech company hopes to have in...


Sanaria Inc. Receives U.S. Army Award for Development of Its Malaria Vaccine
ROCKVILLE, Md., May 2 /PRNewswire/ -- Sanaria Inc., a Rockville, Maryland privately held company focused on development of an attenuated whole parasit...



Lassa Fever

See full description at: http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispage...more

Recent Articles:
Experimental Vaccine Protects Nonhuman Primates From Lassa Fever
FREDERICK, Maryland and WINNIPEG, Manitoba--A team of U.S. and Canadian scientists has developed a vaccine against Lassa fever that fully protects non...



Influenza ( the "flu")

"Regular" flue: The flu is a contagious respiratory illness caused by influenza viruses. It can cause mild to severe illness, and at tim...more

Recent Articles:
Glaxo claims bird flu breakthrough
LONDON, England (Reuters) -- A bird flu vaccine for humans that uses only a very low dose of active ingredient has proved effective in clinical tests ...


GSK bird flu vaccine is the 'best so far'
PHARMACEUTICAL giant GlaxoSmithKline claims to have created the most effective vaccine so far against the deadly H5N1 strain of bird flu.

...


AVANT to Pursue Development of Avian Flu Vaccine
NEEDHAM, Mass.--(BUSINESS WIRE)--Nov. 14, 2005--AVANT Immunotherapeutics, Inc. (NASDAQ: AVAN - News) today announced that it has formed a research tea...

more...

HIV/AIDS

Acquired Immune Deficiency Syndrome (AIDS) was first reported in the United States in 1981 and has since become a major worldwide epidemic. AIDS is ca...more

Recent Articles:
Ex-exec dedicates nonprofit to stop HIV
Donald Francis has spent a quarter century trying to help people with HIV, devoting most of those years to developing a vaccine against the deadly vir...


AIDS vaccine eludes scientists
After 25 years and countless billions of research dollars, some of the nation's top scientists say a vaccine that provides immunity against the virus ...


Monkeys Vaccinated Against SIV Survive Longer After Infection
Results of two new studies sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of H...

more...

FDA

In regards to bioterrorism, the goal of the U.S. Food and Drug Administration (FDA) is to foster the development of vaccines, drugs and diagnostic pro...more

Recent Articles:
Drug, Food Risks Stay Secret as Inquiries to U.S. FDA Pile Up
June 19 (Bloomberg) -- Claudia Krcmarik can't get documents about her father-in-law's death during a medical study. Meryl Nass keeps asking for record...


Senate Approves Tighter Policing of Drug Makers
WASHINGTON, May 9  By a vote of 93 to 1, the Senate passed a bill on Wednesday that would give the Food and Drug Administration new power to police d...


Drug Safety Improvement is Needed in FDA Decision-Making & Oversight, New Study Claims
COSTA MESA CA USA -- MEDICAL INDUSTRY E-MAIL NEWS SERVICE(TM) -- OCT 10 2006 -- In a new issue of Biomedical Market Newsletter(R), a new 31-page repor...

more...

Encephalitis

"Encephalitis" means "inflammation of the brain," but it usually refers to brain inflammation caused by a virus. This severe and potentially life-th...more

E-bola

The Ebola virus is one of the few viruses capable of causing hemorrhagic fever, a severe, often-fatal disease in humans characterised by high fever a...more

Recent Articles:
Study: vaccine may protect against Ebola
U.S. scientists have found a topical respiratory tract vaccine, tested for the first time in primates, might protect against the Ebola virus.

...


Ebola vaccine saves half in post-exposure testing
TORONTO An experimental Ebola vaccine developed in Winnipeg eventually could become the first treatment for people newly infected with the deadly vir...


Ebola DNA Vaccine Produces Immune Responses In All Fully Vaccinated Volunteers In Phase 1 Trial
Vical Incorporated (Nasdaq:VICL) announced today that an Ebola vaccine candidate administered using Vical's proprietary DNA delivery technology was sa...

more...

Detection Technology

This section contains articles about advances in technology which can detect bioterrorism agents in time for treatment.

Recent Articles:
*Universal Detection Technology Receives Purchase Order From the
Universal Detection Technology, a developer and marketer of early-warning monitoring technologies to protect people from bioterrorism, announced to...


Biological weapons unable to hide from Surrey scientists
In autumn 2001 letters containing white powder were posted to several addresses in Florida. The white powder was a form of anthrax and the attack resu...


Anthrax Detection: DHS [Department of Homeland Security] Cannot Ensure That Sampling Activities Will Be Validated
In September and October 2001, contaminated letters laced with Bacillus anthracis were sent through the mail to two U.S. senators and members of the ...

more...

BioShield of 2004

Articles in this section cover vaccine development under the BioShield II Act.

Recent Articles:
Shield Us from Evil
. . .With their firsthand exposure to deadly biological agents, senators are sounding the alarm about the nation's biodefense levels. Two Senate bills...



Anthrax Vaccine



Recent Articles:
KU Med researchers share anthrax discovery
Kansas University Medical Center researchers, along with researchers from Harvard Medical School, the University of Missouri-Kansas City and William J...


HHS evaluates proposals for new anthrax vaccine
Two Maryland pharmaceutical companies recently announced that they have submitted proposals to produce and deliver at least 25 million doses of a next...


DOR BioPharma Acquires Option for Third-Generation Anthrax Vaccine From Harvard University
EWING, NJ--(MARKET WIRE)--May 8, 2008 -- DOR BioPharma, Inc. (OTC BB:DORB.OB - News) ("DOR" or the "Company"), a late-stage biopharmaceutical company,...

more...



Google
www.mvrd.org World Wide Web www.healthsentinel.com
History & Web site manager | Adverse Reactions, Symptoms, and Illnesses | Home | First Steps | Suggestions to help your immune system | Healthcare resources | Mycoplasma and Squalene Discussion | Mission | Anthrax Vaccine | Anthrax Vaccine - Fast Facts | Deployment | Pilots' Corner - Major Thomas L. Rempfer and Lt. Col. Russell E. Dingle | Pilots' Corner - Lt. Col. Jay Lacklen | Pilots' Corner - Lt. Col. Thomas S. Heemstra | In Congress Now | Calendar of Events | News Archives | Smallpox Vaccine | Gulf War Syndrome | History of Human Experimentation | Feres Doctrine | Links | If You Are Refusing A Direct Order To Take A Vaccine | Reference Library | Site Map Contact Us

This website is intended for informational purposes only and is not in any way affiliated with the military.

Website designed and maintained by HealthSentinel.com

©2006 Kathryn D. Hubbell